Vaneck Vectors Pharmaceutical etf shares owned by Neuberger Berman Group
Quarter-by-quarter ownership of Vaneck Vectors Pharmaceutical etf (PPH) shares owned by Neuberger Berman Group
from 13F filings
Historical chart of Neuberger Berman Group investment in Vaneck Vectors Pharmaceutical etf
Tip: Access up to 7 years of quarterly data
All positions including Vaneck Vectors Pharmaceutical etf held by Neuberger Berman Group consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Vaneck Vectors Pharmaceutical etf by Neuberger Berman Group
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $292k | 3.6k | 81.37 |
2023-09-30 | $753k | 9.4k | 79.84 |
2023-06-30 | $363k | 4.6k | 78.75 |
2023-03-31 | $349k | 4.5k | 77.63 |
2022-12-31 | $288k | 3.7k | 77.74 |
2022-09-30 | $249k | 3.7k | 67.18 |
Top funds holding Vaneck Vectors Pharmaceutical etf
View all funds holding Vaneck Vectors Pharmaceutical etf